UroGen Pharma Ltd. (URGN)
43.62
-1.88
(-4.13%)
USD |
NASDAQ |
Aug 28, 16:00
43.61
-0.01
(-0.02%)
After-Hours: 20:00
UroGen Pharma Total Assets (Quarterly) : 252.59M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 252.59M |
| March 31, 2026 | 253.69M |
| December 31, 2025 | 200.46M |
| September 30, 2025 | 185.05M |
| June 30, 2025 | 208.72M |
| March 31, 2025 | 247.62M |
| December 31, 2024 | 285.71M |
| September 30, 2024 | 301.94M |
| June 30, 2024 | 281.85M |
| March 31, 2024 | 200.57M |
| December 31, 2023 | 178.31M |
| September 30, 2023 | 193.63M |
| June 30, 2023 | 95.36M |
| March 31, 2023 | 112.95M |
| December 31, 2022 | 135.62M |
| September 30, 2022 | 128.47M |
| June 30, 2022 | 146.14M |
| March 31, 2022 | 165.72M |
| December 31, 2021 | 119.75M |
| Date | Value |
|---|---|
| September 30, 2021 | 134.60M |
| June 30, 2021 | 153.77M |
| March 31, 2021 | 97.41M |
| December 31, 2020 | 122.00M |
| September 30, 2020 | 139.89M |
| June 30, 2020 | 161.08M |
| March 31, 2020 | 166.93M |
| December 31, 2019 | 202.39M |
| September 30, 2019 | 226.75M |
| June 30, 2019 | 238.57M |
| March 31, 2019 | 252.05M |
| December 31, 2018 | 103.56M |
| September 30, 2018 | 112.56M |
| June 30, 2018 | 121.50M |
| March 31, 2018 | 129.40M |
| December 31, 2017 | 75.55M |
| September 30, 2017 | 81.19M |
| June 30, 2017 | 79.04M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Insmed, Inc. | 2.103B |
| Xencor, Inc. | 724.96M |
| MeiraGTx Holdings Plc | 396.45M |
| IDEAYA Biosciences, Inc. | 1.310B |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 384.99M |
| Shareholders Equity (Quarterly) | -132.40M |
| Debt to Equity Ratio | -1.481 |
| Current Ratio | 3.802 |
| Net Debt Paydown Yield | -0.78% |